Company intelligence / Profile preview

ConquerAb

Gainesville, Florida, USAconquerab.com ↗

Ownership: Private
Development stage: Other

Overview

ConquerAb has developed rapid disposable diagnostic devices that can detect anti-biotherapeutic antibodies in less than 15 minutes from a single drop of blood. These tests are designed for point-of-care or at-home use without the need for trained personnel. The technology enables immunogenicity comparisons between different biotherapeutics used in the same indication and supports precision medicine by stratifying patients based on their antibody status. The company holds three granted U.S. patents covering its core technology.

Therapeutic areas: Immunology
Modalities: Diagnostic device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on ConquerAb.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ConquerAb.

Explore the full profile